Action of lysergide, ephedrine, and nimergoline on brain metabolizing activity.
D000085:Acetates / Q000378:metabolism; D000469:Alkaline Phosphatase / Q000134:cerebrospinal fluid; D000632:Aminopyrine / Q000378:metabolism*; D000818:Animals; D001219:Aspartate Aminotransferases / Q000134:cerebrospinal fluid; D001711:Biotransformation; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002560:Cerebrovascular Circulation / Q000187:drug effects; D003640:Dealkylation; D004285:Dogs; D004809:Ephedrine / Q000494:pharmacology*; D004873:Ergolines / Q000494:pharmacology*; D005965:Glucuronates / Q000378:metabolism; D002534:Hypoxia, Brain / Q000188:drug therapy; D007770:L-Lactate Dehydrogenase / Q000134:cerebrospinal fluid; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology*; D010076:Oxazepam / Q000378:metabolism*; D010101:Oxygen Consumption / Q000187:drug effects; D010477:Perfusion; D013268:Stimulation, Chemical
D000085:Acetates; D004873:Ergolines; D005965:Glucuronates; D000632:Aminopyrine; D010076:Oxazepam; D008238:Lysergic Acid Diethylamide; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D004809:Ephedrine